Loading
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Oct 2026 for Fennec Pharmaceuticals INC., €7,717. Read the official filing
Filing timeline
BuySaleJeffrey Hackman
Insider track record
Disclosed buys
6
Disclosed sells
0
Signal history
No signal scores available.
Jeffrey Hackman: trading record in brief
All filings by Jeffrey Hackman on record concern Fennec Pharmaceuticals Inc. Between 1 June 2026 and 12 October 2026, the trades on record add up to 6 filings.
The open-market record is one-sided, with 6 purchases worth €7,717 and not one sale. No amount is published for 5 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 14 October 2026, reports an open-market purchase of €7,717 in Fennec Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey Hackman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,224 shares@ CA$5.53Common SharesTSXSEDI:4791128
Canonical exit: 10 Jan 2027 (T+90)
1,159 sharesCommon SharesTSXSEDI:4783544
Canonical exit: 30 Dec 2026 (T+90)
1,159 sharesCommon SharesTSXSEDI:4774700
Canonical exit: 3 Dec 2026 (T+90)
1,159 sharesCommon SharesTSXSEDI:4758124
Canonical exit: 1 Nov 2026 (T+90)
1,159 sharesCommon SharesTSXSEDI:4744635
Canonical exit: 29 Sept 2026 (T+90)
1,159 sharesCommon SharesTSXSEDI:4729083
Canonical exit: 30 Aug 2026 (T+90)
6 of 6 declarations
